Behzad Razavi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Behzad Razavi has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Anara Zhumadilova
School of Science and Technology, JSC Nazarbayev University, Astana, Kazakhstan
1 shared publicationAnna-Maria Goerdt
Department of Surgery, Clinic of General, Visceral, Vascular and Thoracic Surgery, University Medicine, Greifswald, Germany
1 shared publicationArne Simon
Clinic of Pediatric Oncology and Hematology, University Medical Center of Saarland, Homburg/Saar, Germany
1 shared publicationAxel Kramer
Institute of Hygiene and Environmental Medicine, University Medicine Greifswald, Ernst-Moritz-Arndt University GreifswaldGermany
1 shared publication- Axel Kramer
University Medicine Greifswald
1 shared publication Bernd Jäger
Institute of Biometrics and Medical Informatics
1 shared publication
Latest Publications
- 6 March 2013
- Published by Taylor & Francis in Cutaneous and Ocular Toxicology
- Vol. 32 (4) , 279-282
Systemic iodine absorption associated with the use of preoperative ophthalmic antiseptics containing iodine
Background: Polyvinylpyrrolidone-Iodine (PVP-I) is routinely used as preoperative antiseptic during ophthalmic surgery. Iodine absorption from iodine-containing antiseptics can lead to the development of thyroid disorders. Therefore, a quantitative measurement of iodine absorption from these antiseptics was performed in patients undergoing elective cataract surgery. Methods: This study enrolled 241 patients to evaluate systemic iodine absorption after exposure to conjunctival and/or periorbital 1.25% and 10% PVP-I compared to an iodine-free antiseptic. Results: All patients who received the 10% PVP-I regardless of the application site showed a 1.2–1.5-fold increase in urinary iodine excretion after 24 h (p = 0.01). In 17 out of 110 (15.5%) patients in whom 10% PVP-I was used, the critical threshold of urinary iodine excretion as defined by WHO (>300 µg/L) was exceeded. In contrast, no significant ioduria was observed with the use of 1.25% PVP-I except in patients after 48 h (p = 0.01) and with a concurrent conjunctival and periorbital application. The proportion of the excreted iodine in urine ranged from 0.24% to 1.77%. No correlation was found between the total applied concentration of iodine and the amount excreted in urine. Conclusion: Based on our findings, we believe that the use of 10% PVP-I as preoperative ophthalmic antiseptic should undergo further clinical evaluation in regard to its impact on thyroid function. Conjunctival or periorbital application of 1.25% PVP-I does not result in significant ioduria.
- 6 March 2013
- Published by Taylor & Francis in Cutaneous and Ocular Toxicology
- Vol. 32 (4) , 279-282
Systemic iodine absorption associated with the use of preoperative ophthalmic antiseptics containing iodine
Background: Polyvinylpyrrolidone-Iodine (PVP-I) is routinely used as preoperative antiseptic during ophthalmic surgery. Iodine absorption from iodine-containing antiseptics can lead to the development of thyroid disorders. Therefore, a quantitative measurement of iodine absorption from these antiseptics was performed in patients undergoing elective cataract surgery. Methods: This study enrolled 241 patients to evaluate systemic iodine absorption after exposure to conjunctival and/or periorbital 1.25% and 10% PVP-I compared to an iodine-free antiseptic. Results: All patients who received the 10% PVP-I regardless of the application site showed a 1.2–1.5-fold increase in urinary iodine excretion after 24 h (p = 0.01). In 17 out of 110 (15.5%) patients in whom 10% PVP-I was used, the critical threshold of urinary iodine excretion as defined by WHO (>300 µg/L) was exceeded. In contrast, no significant ioduria was observed with the use of 1.25% PVP-I except in patients after 48 h (p = 0.01) and with a concurrent conjunctival and periorbital application. The proportion of the excreted iodine in urine ranged from 0.24% to 1.77%. No correlation was found between the total applied concentration of iodine and the amount excreted in urine. Conclusion: Based on our findings, we believe that the use of 10% PVP-I as preoperative ophthalmic antiseptic should undergo further clinical evaluation in regard to its impact on thyroid function. Conjunctival or periorbital application of 1.25% PVP-I does not result in significant ioduria.
- 1 December 2001
- Published by Springer Nature in Infection
- Vol. 29 (6) , 357-358
Herpes Simplex Encephalitis - An Atypical Case
Herpes simplex virus (HSV) is a common cause of viral encephalitis. Herpes simplex encephalitis (HSE) typically presents with acute neurologic changes and the initial cerebrospinal fluid examination is nearly always abnormal. We report a case of a patient with HSE and normal initial CSF analysis. This resulted in delayed diagnosis and therapy with subsequent severe neurolgical sequelae. Herpes simplex infection should be included in the differential diagnosis of encephalopathic patients and a normal CSF examination.
- 1 December 2001
- Published by Springer Nature in Infection
- Vol. 29 (6) , 357-358
Herpes Simplex Encephalitis - An Atypical Case
Herpes simplex virus (HSV) is a common cause of viral encephalitis. Herpes simplex encephalitis (HSE) typically presents with acute neurologic changes and the initial cerebrospinal fluid examination is nearly always abnormal. We report a case of a patient with HSE and normal initial CSF analysis. This resulted in delayed diagnosis and therapy with subsequent severe neurolgical sequelae. Herpes simplex infection should be included in the differential diagnosis of encephalopathic patients and a normal CSF examination.
- 1 November 2000
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 38 (3) , 173-175
Cutaneous infection due to Mycobacterium kansasii
- 1 November 2000
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 38 (3) , 173-175
Cutaneous infection due to Mycobacterium kansasii